Atlas Trials

Safety and Tolerability of the Ophthalmic Solution PRO-179 Compared With Travatan®

Clinical trial NCT03965052 · COMPLETED

Trial details

NCT number
NCT03965052
Sponsor
Laboratorios Sophia S.A de C.V.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Glaucoma
Start date
2019-04-24
Primary completion
2019-07-02
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.